🇺🇸 FDA
Patent

US 7109210

Quinuclidine derivatives and medicinal compositions containing the same

granted A61KA61K31/439A61K31/4745

Quick answer

US patent 7109210 (Quinuclidine derivatives and medicinal compositions containing the same) held by Almirall Prodesfarma S.A. expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/439, A61K31/4745, A61K31/56, A61K45/06